Global Industry Analysis, E-Pharmacies Market Share 2019- By Key Players, Segmentation, Trends and Forecast By 2026

An internet pharmacy also is known as e-pharmacy is a pharmacy that operates over the internet. These pharmacies provide services like sending orders to customers through mail or shipping companies. Validation and good distribution practices are followed systematically. Home delivery of pharmaceuticals is a desirable convenience.
Shipments by express mail and couriers reduce transit time and offer superfast services that often involves delivery to the door. The use of appropriate insulated shipping containers also helps control drug temperatures, reducing risks to drug safety and efficiency.

Patient safety and prescription error reduction are majorly considered in the context of modern health care. Errors like an incorrect or unavailable drug, dosage form, duplication of therapy, the omission of information, and misinterpretation of the order because of illegible handwriting are easily avoided forms the major reasons for the growth of the market. E-prescribing software is equipped with point-of-care support that notifies the provider of prescription errors before transmission. Various services provided to verify allergies, confirm dosage accuracy, and identify drug-drug interactions before the prescription is transmitted, access to insurance information, formulary decision support (FDS), and fill status notification are features that increase the probability of the provider selecting a commercially available dosage form and a generic equivalent, if applicable. Electronic storage of prescription records proves to be the most beneficial factor driving market growth.

Clinical benefits of e-prescribing as well are dominant factors that are boosting the market growth. E-prescribing streamlines prescription processing and reduces wait times since patients need not be present before a prescription. Calls to the provider’s office to clarify illegible orders are eliminated, affording the pharmacist more time to counsel patients. All the features from reduced health care costs and healthier employees provided by this technology boost the market growth.

The global e-pharmacy market is segmented on the basis of drug type and product type. On the basis of drug type, it is divided into prescription drugs and over the counter drugs (OTD). On the basis of product type, further segmentations are made including skincare, dental, cold and flu, vitamins, weight loss, and various other product types.
Geographically, the market is dominated by North American regions as these regions dominate the global E-pharmacies market due to the high number of internet users and high adaptability to online services.

India is considered as the fastest growing market in Asia Pacific region for global E-pharmacies market due to an increase in the number of e-pharmacies, cost-effectiveness and fast track delivery at doorstep, and expected to rise during the forecast period. Various other regions including Europe, Latin America, Middle-East-Africa are also developing the global e-pharmacy market.
E-prescribing is initially facing many challenges, making resistance by pharmacists and providers difficult to overcome.

Benefits provided by e-pharmacies such as availability of medicines at affordable prices, access to information on the prescribed data, shift towards self-diagnosing from the direct doctor-patient relations and increase in digital health is driving the e-pharmacies market, and is also expected to remain high over the forecast period. Huge discounts from e-commerce companies have lured consumers to shop more than required. E-pharmacies can save as much as 95% on medication compared with local pharmacies.

Related Posts

  • Pharma
  • April 28, 2025
  • 99 views
Gujrat leads pharma sector with record 183 new plants

Ahmedabad:  Gujarat has further cemented its position as India’s pharmaceutical powerhouse with the state’s Food and Drug Control Administration (FDCA) approving 183 new allopathic drug manufacturing facilities in FY 2024-25,…

  • Pharma
  • April 28, 2025
  • 108 views
Doctor not liable for prescribing costly drug: HC

Cuttack:  Orissa high court has ruled that a doctor should not be held criminally liable for prescribing a particular drug of any pharmaceutical company for treatment of a disease like…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gujrat leads pharma sector with record 183 new plants

Gujrat leads pharma sector with record 183 new plants

Doctor not liable for prescribing costly drug: HC

Doctor not liable for prescribing costly drug: HC

878 Tramadol capsules being smuggled in Scorpio seized, three arrested

878 Tramadol capsules being smuggled in Scorpio seized, three arrested

Doctor not criminally liable for prescribing costly drug: Orissa High Court

Doctor not criminally liable for prescribing costly drug: Orissa High Court